Clinical trial
Celecoxib in Preventing Lung Cancer in Former Heavy Smokers
NCT00055978 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00055978 |
|---|---|
| Title | Celecoxib in Preventing Lung Cancer in Former Heavy Smokers |
| Official title | Lung Cancer Chemoprevention With Celecoxib In Ex-Smokers |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Other |
| Interventions | celecoxib, placebo |
| Enrollment | 112 |
| Start date | Oct 1, 2002 |
| Primary completion | Mar 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Mar 7, 2003 |
| Last update posted | Jun 20, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: